Johnson & Johnson to stop selling talc-based baby powder in U.S. and Canada

(Reuters) - Johnson & Johnson on Tuesday announced that it would stop selling its talc-based Johnson's Baby Powder in the United States and Canada, making the decision after a consumer products "portfolio reassessment related to COVID-19." The U.S. healthcare conglomerate said it would wind down sales of the product, which makes up about 0.5% of its U.S. consumer health business, in the coming months, but that retailers will continue to sell existing inventory. J&J faces more than 16,000..